2,761
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Therapeutic antibodies to intracellular targets in cancer therapy

, &
Pages 1485-1488 | Published online: 31 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mariano R. Gabri, Walter Cacciavillano, Guillermo L. Chantada & Daniel F. Alonso. (2016) Racotumomab for treating lung cancer and pediatric refractory malignancies. Expert Opinion on Biological Therapy 16:4, pages 573-578.
Read now

Articles from other publishers (13)

Ahmed A. M. Ahmed, Ahmed E. M. Mekky & Sherif M. H. Sanad. (2021) Effective synthesis of new benzo-fused macrocyclic and heteromacrocyclic bis(Schiff bases). Journal of the Iranian Chemical Society 19:5, pages 1711-1722.
Crossref
Ahmed A. M. Ahmed, Ahmed E. M. Mekky & Sherif M. H. Sanad. (2021) Effective synthesis of new benzo‐fused macrocyclic and thiamacrocyclic dilactams and related pyrazolo‐fused macrocycles. Journal of Heterocyclic Chemistry 59:2, pages 286-296.
Crossref
Anne Yau, Jinhyung Lee & Yupeng Chen. (2021) Nanomaterials for Protein Delivery in Anticancer Applications. Pharmaceutics 13:2, pages 155.
Crossref
Heather F. Jones, Zaki Molvi, Martin G. Klatt, Tao Dao & David A. Scheinberg. (2021) Empirical and Rational Design of T Cell Receptor-Based Immunotherapies. Frontiers in Immunology 11.
Crossref
Jiang Chang, Zeng-Shan Liu, De-Feng Song, Meng Li, Song Zhang, Ke Zhao, Yu-Ting Guan, Hong-Lin Ren, Yan-Song Li, Yu Zhou, Xi-Lin Liu, Shi-Ying Lu & Pan Hu. (2020) Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target. Journal of Cancer Research and Clinical Oncology 146:9, pages 2205-2217.
Crossref
Jose R. Conejo-Garcia, Subir Biswas & Ricardo Chaurio. (2020) Humoral immune responses: Unsung heroes of the war on cancer. Seminars in Immunology 49, pages 101419.
Crossref
Pallavi Sabharwal, C. Sushmitha, C. K. Amritha, Usha Natraj, Mathur R. N. Murthy & Handanahal S. Savithri. (2020) Development of pepper vein banding virus chimeric virus-like particles for potential diagnostic and therapeutic applications. Archives of Virology 165:5, pages 1163-1176.
Crossref
Lauren Nicholls & Lisa M. Kopp. 2020. Cancer Immunology. Cancer Immunology 49 73 .
Yichao Huang, Mareike Margarete Wiedmann & Hiroaki Suga. (2018) RNA Display Methods for the Discovery of Bioactive Macrocycles. Chemical Reviews 119:17, pages 10360-10391.
Crossref
Toni Jauset & Marie-Eve Beaulieu. (2019) Bioactive cell penetrating peptides and proteins in cancer: a bright future ahead. Current Opinion in Pharmacology 47, pages 133-140.
Crossref
Andrew M. Davis, Alleyn T. Plowright & Eric Valeur. (2017) Directing evolution: the next revolution in drug discovery?. Nature Reviews Drug Discovery 16:10, pages 681-698.
Crossref
Nicholas Veomett, Tao Dao, Hong Liu, Jingyi Xiang, Dmitry Pankov, Leonid Dubrovsky, Joseph A. Whitten, Sun-Mi Park, Tatyana Korontsvit, Victoria Zakhaleva, Emily Casey, Michael Curcio, Michael G. Kharas, Richard J. O'Reilly, Cheng Liu & David A. Scheinberg. (2014) Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein. Clinical Cancer Research 20:15, pages 4036-4046.
Crossref
Leonid Dubrovsky, Dmitry PankovElliott Joseph Brea, Tao DaoAndrew ScottSu Yan, Richard J O’ReillyCheng Liu & David A. Scheinberg. (2014) A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias. Blood 123:21, pages 3296-3304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.